Skip to main content
NIH funding notice RFA-RM-16-027

Stimulating Peripheral Activity to Relieve Conditions (SPARC): Pre-clinical Development of Existing Market-approved Devices to Support New Market Indications (U18)

Closed on December 21, 2016.

Posted
October 19, 2016
Close date
December 21, 2016
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,637,396 in first-year total cost, median $818,698.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 ETTN-B (55)]2

Most frequent institutions

  1. INDIANA UNIVERSITY INDIANAPOLIS1
  2. UNIVERSITY OF PITTSBURGH AT PITTSBURGH1
Competing awards under RFA-RM-16-027 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2017Closed-loop neuroelectric control of emesis and gastric motility1U18TR002205-01HORN, CHARLES CHRISTOPHERUNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA$960,848ZRG1
2017Subcutaneous nerve stimulation for arrhythmia control.1U18TR002208-01CHEN, PENG-SHENGINDIANA UNIVERSITY INDIANAPOLIS, IN$676,548ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-RM-16-027: Stimulating Peripheral Activity to Relieve Conditions (SPARC): Pre-clinical Development of Existing Market-approved Devices to Support New Market Indications (U18) | ScienceDex | ConductScience